StemCells Therapy

Every few days my Google Alerts have been dropping in my inbox reviews of Harry Osters Legacy: A Genetic History of the Jewish People. The latest, is in the The Tablet, A Case for Genetic Jewishness: For a Jewish genetics researcher, being told inprintthat Hitler would certainly have been very pleased by your work cant be pleasant.

Researchers may be closing in on diseases inherited component Web edition : 1:40 pm Schizophrenias elusive genetic roots may finally be within grasp. A new, wide-ranging effort has uncovered a set of DNA signatures that are shared by people with the disease consistently enough that the set can be used to reliably predict whether someone has the disease.

Published on May 14, 2012 at 12:51 AM Cancer therapies targeting specific molecular subtypes of the disease allow physicians to tailor treatment to a patient’s individual molecular profile. But scientists are finding that in many types of cancer the molecular subtypes are more varied than previously thought and contain further genetic alterations that can affect a patient’s response to therapy

Log in to manage your products and services from The New York Times and the International Herald Tribune. Don’t have an account yet? Create an account E-Mail or Member ID Password Remember Me Log In

Researchers at Washington University School of Medicine in St. Louis have developed a genetic test that can accurately predict whether the most common form of eye cancer will spread to other parts of the body, particularly the liver. In 459 patients with ocular melanoma at 12 centers in the United States and Canada, the researchers found the test could successfully classify tumors more than 97 percent of the time.

Log in to manage your products and services from The New York Times and the International Herald Tribune. Don’t have an account yet? Create an account E-Mail or Member ID Password Remember Me Log In

In households across the country, children conceived with donated sperm are struggling with serious genetic conditions inherited from men they have never met: heart defects, spinal muscular atrophy, neurofibromatosis type 1 and fragile-X syndrome the most common form of mental retardation in boys and others. Donated eggs pose a risk as well, but the threat of genetic harm from sperm donation is arguably much greater

Public release date: 14-May-2012 [ | E-mail | Share ] Contact: Jim Dryden jdryden@wustl.edu 314-286-0110 Washington University School of Medicine Researchers at Washington University School of Medicine in St.

Scientists have uncovered genetic signs that could help doctors predict how breast cancer patients will respond to chemotherapy. Researchers led by McMaster University biochemist John A.

Newswise Melanoma the deadliest and most aggressive form of skin cancer has long been linked to time spent in the sun. Now a team led by scientists from the Broad Institute and Dana-Farber Cancer Institute has sequenced the whole genomes of 25 metastatic melanoma tumors, confirming the role of chronic sun exposure and revealing new genetic changes important in tumor formation. In an article published online May 9 in Nature, the authors provide the first high-resolution view of the genomic landscape of human melanoma tumors

With the support of a Major League Baseball star, a new University of Florida research center on an island settled by the Vikings could lead to breakthroughs about a rare genetic disorder and potentially change the course of care for high blood pressure and other common conditions. UF College of Medicine researchers studying a genetic condition called glycogen storage disease type III, which prevents children and adults from properly processing sugar stored in the body, have received support from the Johnny Damon Foundation to establish a new research center on the Faroe Islands, located in the North Atlantic Ocean between Norway and Iceland. Because of the isolation of the island chain, genetic diseases are common there, making it a fertile ground for researchers.

May 11, 2012 Connie K. Ho for RedOrbit.com Researchers at Loyola University Chicagos Stritch School of Medicine have found that patients see both benefits and risks from direct-to-consumer genetic tests. Dr.

Public release date: 11-May-2012 [ | E-mail | Share ] Contact: Dianne G. Shaw dgs@med.unc.edu 919-966-7834 University of North Carolina School of Medicine Cancer therapies targeting specific molecular subtypes of the disease allow physicians to tailor treatment to a patient’s individual molecular profile. But scientists are finding that in many types of cancer the molecular subtypes are more varied than previously thought and contain further genetic alterations that can affect a patient’s response to therapy.

Public release date: 10-May-2012 [ | E-mail | Share ] Contact: Dr.

07-05-2012 12:34 Autism, just like any chronic health condition, is the result of genetic predispositions interacting with modifiable environmental factors. The key is to identify the contributing factors in each case. Some of the common factors include nutrient insufficiencies, toxin exposure, food allergies, intestinal yeast overgrowth, infections, and more

Michael Pacanowski, PharmD, MPH; Shashi Amur, PhD; Issam Zineh, PharmD, MPH Author Affiliations: Genomics Group, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland. Treatment of chronic hepatitis C (CHC) is a prototype for personalized medicine

Dell: WHAT The team of parents, genetic and translational medicine scientists and pediatric oncologists trailblazing personalized medicine in the treatment of deadly pediatric cancers is convening in Austin to discuss the status of the worlds first personalized medicine clinical trial for pediatric cancer and plan next steps at the NMTRC Symposium 2012. Neuroblastoma affects 1 in 100,000 children and is responsible for 1 in 7 pediatric cancer deaths.

Public release date: 7-May-2012 [ | E-mail | Share ] Contact: David Sampson ajpmedia@elsevier.com 215-239-3171 Elsevier Health Sciences Philadelphia, PA, May 7, 2012 While active monitoring of serum prostate specific antigen (PSA) levels in men over 50 has greatly improved early detection of prostate cancer, prediction of clinical outcomes after diagnosis remains a major challenge. Researchers from the University of Pittsburgh School of Medicine have found that a genetic abnormality known as copy number variation (CNV) in prostate cancer tumors, as well as in the benign prostate tissues adjacent to the tumor and in the blood of patients with prostate cancer, can predict whether a patient will experience a relapse, and the nature of the relapse aggressive or indolent. Their report is published in the June issue of The American Journal of Pathology.

Maximum likelihood methods for the estimation of linkage disequilibrium between biallelic DNA-markers in half-sib families (half-sib method) are developed for single and multifamily situations. Monte Carlo computer simulations were carried out for a variety of scenarios regarding sire genotypes, linkage disequilibrium, recombination fraction, family size, and number of families. A double heterozygote sire was simulated [...]

Quite a few methods have been proposed to infer sibship and parentage among individuals from their multilocus marker genotypes. They are all based on Mendelian laws either qualitatively (exclusion methods) or quantitatively (likelihood methods), have different optimization criteria, and use different algorithms in searching for the optimal solution. The full-likelihood method assigns sibship and parentage [...]